Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks Up; Powell To Make Jackson Hole Debut

Fri, 24th Aug 2018 11:54

LONDON (Alliance News) - Stocks in London were marginally higher at midday on Friday ahead of a highly anticipated speech from the head of the US Federal Reserve.With US-China trade talks demoting a lack of significant progress, investors will now shift focus to a speech by Federal Reserve Chairman Jerome Powell in the afternoon for fresh updates on the outlook for the US economy. Investors also adopted a cautious stance ahead of the long bank holiday weekend in the UK.The FTSE 100 index was up 0.1%, or 10.10 points at 7,573.32. The FTSE 250 was up 0.2%, or 31.14 points, at 20,696.00, and the AIM All-Share was down 0.3%, or 3.69 points, at 1,088.86.The Cboe UK 100 was up 0.1% at 12,831.08, the Cboe UK 250 was up 0.1% at 18,783.21, and the Cboe UK Small Companies was up 0.1% at 12,342.86.On the London Stock Exchange, Antofagasta was the best blue chip performer, up 3.2% after RBC Capital upgraded the Chilean copper miner to Outperform from Sector Perform. Shire was up 2.2% after the US Food & Drug Administration has approved the Irish pharmaceutical company's Takhzyro drug to treat a rare genetic disease. The disease, hereditary angioedema, causes attacks of swelling in different parts of the body and can be life-threatening. Approval from the FDA follows a phase III study of 125 patients in which Takhzyro reduced monthly attacks by, on average, 87% in patients when compared with a placebo.Miners were also higher with Anglo American, up 1.6%, Rio Tinto, up 1.1%, BHP Billiton, up 1.1%. "A rebound in copper, platinum and palladium has helped mining stocks. The cooling of the Chinese economy has triggered major volatility in the metals market, as investors are worried about future demand. For the time being, the size of the tariffs being imposed on Chinese goods imported into the US are relatively small, but if it is drawn out, it could chip away at growth," said David Madden, market analyst at CMC Markets.Conversely, housebuilders were weighing on the large cap index amid a decline in UK mortgage approval figures in July.Berkeley Group was down 1.8%, Barratt Developments, down 1.6%, Persimmon, down 1.1%, Taylor Wimpey, down 1.0%.The number of mortgages approved in July fell to 39,584 from 40,330 in June. Economists had forecast approvals to rise to 40,650, data from UK Finance showed. "Housebuilders have taken a knock as a double whammy of lower new approved mortgages and a five-month low in mortgage lending weighed on the sector," IG Group analyst Chris Beauchamp said. Additionally, midcap peers McCarthy & Stone, Bovis Homes and Bellway were down 1.6%, 1.4% and 0.9%, respectively. Sterling was quoted at USD1.2823 at midday, compared to USD1.2830 at the London equities close on Thursday. The pound was flat with investors unmoved by new details covering a "no deal" Brexit unveiled by Brexit Secretary Dominic Raab on Thursday. In mainland Europe, the CAC 40 in Paris was up 0.5% while the DAX 30 in Frankfurt was up 0.2%.The euro was flat against the dollar quoted at USD1.1565 at midday, from USD1.1569 at the European equities close Thursday, following solid Germany GDP data. Germany's economy expanded at a faster pace as initially estimated on domestic demand in the second quarter, detailed data from Destatis showed.The largest euro area economy grew 0.5% sequentially, following the 0.4% increase in the first quarter. The rate came in line with the estimate released on August 14.On a yearly basis, gross domestic product advanced at a faster pace of 2.3% after expanding 1.4% a quarter ago. Meanwhile, the calendar-adjusted GDP growth slowed slightly to 2% from 2.1%. Both annual rates matched expectations.Stocks in New York were set for a higher open as Fed Chair Powell gets set to take the stage at the Economic Policy Symposium in Jackson Hole.The DJIA, the S&P 500 index and the Nasdaq Composite were all called up 0.2%.Powell will make his maiden address to some of the world's most prominent central bankers at the gathering in Wyoming at 1500 BST, a week after US President Donald Trump took aim at the Fed chair.Earlier this week, the Fed has pencilled in two more interest rate hikes this year despite risks from trade conflicts and emerging market turmoil.In response, Trump reiterated his criticism of the Fed's monetary policy, saying he was "not thrilled" with the central bank for raising interest rates and that it should do more to help boost the US economy. It remains to be seen whether Powell will respond to Trump's criticism.Powell was hand picked by Trump to lead the US central bank.
More News
24 Aug 2018 10:39

WINNERS & LOSERS SUMMARY: Shire Rises As US FDA Approves Takhzyro Drug

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 2.6%. The Irish pharmaceutical company said a

Read more
24 Aug 2018 08:38

LONDON MARKET OPEN: Stocks Mixed, Shire Rises After Drug Approval

LONDON (Alliance News) - Stock prices in London were mixed early Friday, as markets await US Federal Reserve Chair Jerome Powell's speech in Wyoming later in the day. In the large cap index rose

Read more
24 Aug 2018 08:06

FDA gives nod to Shire's TAKHZYRO treatment

(Sharecast News) - Shire announced on Friday that, following priority review, the US Food and Drug Administration (FDA) has approved the 'TAKHZYRO' (lanadelumab-flyo) injection for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients 12 years of age and older.

Read more
24 Aug 2018 07:41

LONDON MARKET PRE-OPEN: Slightly Lower Call Ahead Of Powell Speech

LONDON (Alliance News) - Stock prices in London are seen lower on Friday ahead of US Federal Reserve Chair Jerome Powell's speech later during the day, while in a quiet day for UK company news In

Read more
13 Aug 2018 10:31

WINNERS & LOSERS SUMMARY: Chemring Says Fatal Accident To Hurt Profit

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------BAE up 0.8%. a

Read more
13 Aug 2018 09:21

Shire Partner Shionogi Files New Drug Application For Intuniv In Japan

LONDON (Alliance News) - Irish drugmaker Shire PLC said on Monday its Japanese partner Shionogi & Co Ltd has submitted a new drug application for the manufacture and marketing of Intuniv in is

Read more
13 Aug 2018 07:51

Shire and Shionogi apply to expand ADHD treatment to adults

(Sharecast News) - Shire and Shionogi have applied to expand the use in Japan of co-developed drug Intuniv to treat adults for attention deficit hyperactivity disorder.

Read more
31 Jul 2018 12:51

TOP NEWS: Shire Income Up In 2nd-Quarter Ahead Of Takeover By Takeda

LONDON (Alliance News) - Irish biotechnology company Shire PLC on Tuesday posted a more than doubled pretax income in the second quarter, ahead of its upcoming takeover by Takeda Pharmaceutical Co

Read more
31 Jul 2018 12:12

Shire posts 4 pct rise in Q2 earnings ahead of sale to Takeda

LONDON, July 31 (Reuters) - Shire, the London-listed pharmaceutical group being bought by Japan's Takeda, reported a 4 percent rise in second-quarter earnings as revenue rose 5 percent to just

Read more
31 Jul 2018 12:08

Shire's quarterly sales rise on immunology demand

(Sharecast News) - Shire reported healthy sales growth in the second quarter as the biotech company pressed ahead with its acquisition by Takeda of Japan.

Read more
31 Jul 2018 08:05

UPDATE 1-Takeda posts weakest Q1 profit in three years

* Q1 operating profit Y98.9 bln vs Y195 bln a year earlier * Takeda booked gains from asset sales a year earlier (Adds details) TOKYO, July 31 (Reuters) - Japan's Takeda Co Ltd a

Read more
25 Jul 2018 07:00

RPT-ANALYSIS-Buy yen in crisis? Not this year

* Yen weakest G10 currency this month despite global turbulence * Investors doubt BOJ can reduce stimulus aggressively * Japanese purchases of foreign equities highest in nearly Bond

Read more
24 Jul 2018 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 25 July GlaxoSmithKlineHalf Year Results (at 1200 BST)Vodafone GroupTrading 26

Read more
24 Jul 2018 15:08

ANALYSIS-Buy yen in crisis? Not this year

* Yen weakest G10 currency this month despite global turbulence * Investors doubt BOJ can reduce stimulus aggressively * Japanese purchases of foreign equities highest in nearly Bond

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.